BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3125963)

  • 1. Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator.
    Humphries MJ; Matsumoto K; White SL; Molyneux RJ; Olden K
    Cancer Res; 1988 Mar; 48(6):1410-5. PubMed ID: 3125963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
    Gorelik E
    Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
    Kalland T
    Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
    Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
    J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors.
    Humphries MJ; Matsumoto K; White SL; Olden K
    Cancer Res; 1986 Oct; 46(10):5215-22. PubMed ID: 3093061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states.
    Butler LD; Browne CP; Layman NK; Riedl P; Tang J; Marder P; DeLong D; Manetta J; Bobbitt L; Strnad J
    Cancer Res; 1988 Nov; 48(21):6081-9. PubMed ID: 3048654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
    Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of intravascular mouse melanoma dissemination by recombinant human interferon alpha A/D.
    Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N
    Jpn J Cancer Res; 1986 Jan; 77(1):80-4. PubMed ID: 3082819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH; Wallace TL; Richard KA; Tracey DE
    Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
    Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
    Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes.
    Kawano Y; Taniguchi K; Toshitani A; Nomoto K
    J Immunol; 1986 Jun; 136(12):4729-34. PubMed ID: 3711664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
    Yang H; Yogeeswaran G; Bukowski JF; Welsh RM
    Nat Immun Cell Growth Regul; 1985; 4(1):21-39. PubMed ID: 3875791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modulation of B16BL6 melanoma metastasis is not directly mediated by cytolytic activity of natural killer cells in alcohol-consuming mice.
    Spitzer JH; Núñez NP; Meadows SA; Gallucci RM; Blank SE; Meadows GG
    Alcohol Clin Exp Res; 2000 Jun; 24(6):837-44. PubMed ID: 10888072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
    Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swainsonine: a new antineoplastic immunomodulator.
    Mohla S; Humphries MJ; White SL; Matsumoto K; Newton SA; Sampson CC; Bowen D; Olden K
    J Natl Med Assoc; 1989 Oct; 81(10):1049-56. PubMed ID: 2509720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of natural killer cell activity and tumor immunity by diacetylputrescine.
    Bowlin TL; Rosenberger A; Stemerick D; Edwards ML
    Cancer Res; 1990 Sep; 50(17):5460-3. PubMed ID: 2386950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimetastatic action of polyactin A and its mechanism].
    Qiang WA; Liu JR; Wang YS; Lei YD
    Yao Xue Xue Bao; 1994; 29(5):340-5. PubMed ID: 7976351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.